Drug intelligence / Profile preview

Retaron

Development stage
Unknown
Lead developer
URSAPHARM Arzneimittel
Modality
Small Molecules
Administration
Oral
01

Overview

Retaron is a dietary supplement, specifically classified as a Food for Special Medical Purposes (FSMP), developed for the dietary management of age-related macular degeneration (AMD). It is characterized by its inclusion of Aronia berry (chokeberry) extract, which provides a high concentration of anthocyanins and other polyphenols that exert potent antioxidant and anti-inflammatory effects within the ocular tissues. In addition to Aronia extract, Retaron contains the carotenoids lutein and zeaxanthin, which accumulate in the macula to filter high-energy blue light and neutralize singlet oxygen. The formulation is further supported by essential trace elements (zinc and selenium) and vitamins (C and E) that serve as cofactors for endogenous antioxidant enzymes or directly scavenge free radicals. Together, these components aim to slow the progression of AMD by protecting retinal pigment epithelial cells and photoreceptors from oxidative stress-induced damage.

Brand names
Retaron
Other names
vitamin and mineral supplementantioxidant supplement

Beyond the preview

Go deeper on Retaron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retaron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call